‘Dream come true’: study suggests drug could extend women’s fertility by five years

Early results in women up to the age of 35 suggest it is realistic to hope rapamycin can decrease ovary ageing by 20%.

A drug that could extend women’s fertility by five years — and help them live longer in better health — is safe for a young, healthy population, according to early results of a study.

The research into repurposing the immunosuppressant rapamycin has been hailed a “paradigm shift” in how menopause is studied.